Moreover, to determine the relative uptake of TDEV when tumour cells were present, PKH-26 labelled TDEV were added to tumour:PBMC co-cultures, and the percentage of TDEV positive tumour (CD45-) and CD14+ cells was assessed using flow cytometry (Figure 1D). This evidence concerns the gene PTPRC and neoplasm.